Trials / Sponsors / AnGes USA, Inc.

AnGes USA, Inc.

Industry · 6 registered clinical trials.

Status	Trial	Phase	Started
Unknown	Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers Peripheral Artery Disease, Ischaemic Ulcer of Lower Leg Due to Atherosclerotic Disease, Chronic Limb Threatening Ischemia	Phase 2	2020-01-30
Completed	A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia Critical Limb Ischemia	—	2017-02-20
Terminated	Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia Critical Limb Ischemia	Phase 3	2014-11-12
Completed	A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia Critical Limb Ischemia, Vascular Diseases, Peripheral Arterial Disease	Phase 2	2013-11-01
Completed	Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Pati Arterial Occlusive Disease, Peripheral Vascular Disease, Ischemia	Phase 2	2005-08-01
Completed	Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Arterial Occlusive Disease, Peripheral Vascular Disease, Ischemia	Phase 2	2003-04-01